Stay in touch
Prime news from our network.
#read
Record year for new drugs in Germany
The pharmaceutical industry in Germany can look back on an outstanding year in 2024: a total of 43 drugs with innovative active ingredients were launched on the market - a significant increase compared to the 30 new launches in 2023 and the fourth-best result in the last 20 years. In addition, there were 22 extensions of marketing authorisations for existing drugs that cover new clinical pictures.
17/12/2024
Development in cancer therapy was particularly strong with eleven new drugs, including six kinase inhibitors. Two new reserve antibiotics for the treatment of multi-resistant bacteria and two vaccines - against RSV and rabies - were also launched on the market. In addition, 27 of the new drugs (63 per cent) are aimed at patients with rare diseases, 18 of which have been granted orphan drug status.
A notable trend is the increasing use of chemically synthesised active ingredients, which were used in 70 percent of the new drugs. Germany plays an important role in clinical testing: 72 per cent of new drugs were tested in German clinics and practices.News from "vfa - Verband Forschender Arzneimittelhersteller e.V." from 17.12.2024
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.